Paul Bangirana1, Robert O Opoka2, Michael J Boivin3, Richard Idro2, James S Hodges4, Regilda A Romero5, Elsa Shapiro6, Chandy C John7. 1. Department of Psychiatry, and. 2. Department of Paediatrics and Child Health, Makerere University College of Health Sciences, Kampala, Uganda. 3. Department of Psychiatry, Michigan State University School of Human Medicine, East Lansing. 4. Department of Biostatistics, and. 5. Department of Pediatrics, University of Minnesota Medical School, Minneapolis. 6. Department of Epidemiology, University of Minnesota School of Public Health, and. 7. Department of Biostatistics, and Department of Epidemiology, University of Minnesota School of Public Health, and.
Abstract
BACKGROUND: Cerebral malaria (CM) is associated with long-term neurocognitive impairment in children ≥5 years of age. No prospective studies to date have assessed neurocognitive impairment in children with CM <5 years of age, or in children with severe malarial anemia (SMA), a form of severe malaria estimated to affect as many as 5 million children annually. METHODS: Children <5 years of age presenting to Mulago Hospital, Kampala, Uganda, with CM (n = 80) or SMA (n = 86) were assessed for overall cognitive ability, attention, and associative memory 1 week after discharge and 6 and 12 months later. The z scores for each domain were computed based on scores of 61 healthy community children (CC), who were also tested at enrollment and 6 and 12 months later. Groups were compared using mixed linear models, adjusted for age, weight for age, and child's education. RESULTS: At 12 months, children with CM had lower adjusted scores than CC in cognitive ability (P < .001), attention (P = .02), and associative memory, (P = .002). Children with SMA had lower scores than CC in cognitive ability (P = .01) but not attention or associative memory. Cognitive ability scores in children with CM and SMA did not differ significantly. CONCLUSIONS: In children <5 years of age, SMA is associated with long-term impairment in cognitive ability, whereas CM is associated with additional impairment in the areas of attention and associative memory. SMA may be a major contributor to long-term neurocognitive impairment in children in sub-Saharan Africa.
BACKGROUND:Cerebral malaria (CM) is associated with long-term neurocognitive impairment in children ≥5 years of age. No prospective studies to date have assessed neurocognitive impairment in children with CM <5 years of age, or in children with severe malarial anemia (SMA), a form of severe malaria estimated to affect as many as 5 million children annually. METHODS:Children <5 years of age presenting to Mulago Hospital, Kampala, Uganda, with CM (n = 80) or SMA (n = 86) were assessed for overall cognitive ability, attention, and associative memory 1 week after discharge and 6 and 12 months later. The z scores for each domain were computed based on scores of 61 healthy community children (CC), who were also tested at enrollment and 6 and 12 months later. Groups were compared using mixed linear models, adjusted for age, weight for age, and child's education. RESULTS: At 12 months, children with CM had lower adjusted scores than CC in cognitive ability (P < .001), attention (P = .02), and associative memory, (P = .002). Children with SMA had lower scores than CC in cognitive ability (P = .01) but not attention or associative memory. Cognitive ability scores in children with CM and SMA did not differ significantly. CONCLUSIONS: In children <5 years of age, SMA is associated with long-term impairment in cognitive ability, whereas CM is associated with additional impairment in the areas of attention and associative memory. SMA may be a major contributor to long-term neurocognitive impairment in children in sub-Saharan Africa.
Authors: J Crawley; C Waruiru; S Mithwani; I Mwangi; W Watkins; D Ouma; P Winstanley; T Peto; K Marsh Journal: Lancet Date: 2000-02-26 Impact factor: 79.321
Authors: Michael J Boivin; Paul Bangirana; Justus Byarugaba; Robert O Opoka; Richard Idro; Anne M Jurek; Chandy C John Journal: Pediatrics Date: 2007-01-15 Impact factor: 7.124
Authors: Waldemar A Carlo; Shivaprasad S Goudar; Omrana Pasha; Elwyn Chomba; Jan L Wallander; Fred J Biasini; Elizabeth M McClure; Vanessa Thorsten; Hrishikesh Chakraborty; Dennis Wallace; Darlene L Shearer; Linda L Wright Journal: J Pediatr Date: 2012-11-16 Impact factor: 4.406
Authors: Michael J Boivin; Melissa J Gladstone; Maclean Vokhiwa; Gretchen L Birbeck; Jed G Magen; Connie Page; Margaret Semrud-Clikeman; Felix Kauye; Terrie E Taylor Journal: Trop Med Int Health Date: 2010-12-08 Impact factor: 2.622
Authors: Gretchen L Birbeck; Malcolm E Molyneux; Peter W Kaplan; Karl B Seydel; Yamikani F Chimalizeni; Kondwani Kawaza; Terrie E Taylor Journal: Lancet Neurol Date: 2010-11-04 Impact factor: 44.182
Authors: Chandy C John; Paul Bangirana; Justus Byarugaba; Robert O Opoka; Richard Idro; Anne M Jurek; Baolin Wu; Michael J Boivin Journal: Pediatrics Date: 2008-06-09 Impact factor: 7.124
Authors: Ashajyothi M Siddappa; Michael K Georgieff; Sandi Wewerka; Cathy Worwa; Charles A Nelson; Raye-Ann Deregnier Journal: Pediatr Res Date: 2004-06 Impact factor: 3.756
Authors: Lorenz von Seidlein; Rasaq Olaosebikan; Ilse C E Hendriksen; Sue J Lee; Olanrewaju Timothy Adedoyin; Tsiri Agbenyega; Samuel Blay Nguah; Kalifa Bojang; Jacqueline L Deen; Jennifer Evans; Caterina I Fanello; Ermelinda Gomes; Alínia José Pedro; Catherine Kahabuka; Corine Karema; Esther Kivaya; Kathryn Maitland; Olugbenga A Mokuolu; George Mtove; Juliet Mwanga-Amumpaire; Behzad Nadjm; Margaret Nansumba; Wirichada Pan Ngum; Marie A Onyamboko; Hugh Reyburn; Tharisara Sakulthaew; Kamolrat Silamut; Antoinette K Tshefu; Noella Umulisa; Samwel Gesase; Nicholas P J Day; Nicholas J White; Arjen M Dondorp Journal: Clin Infect Dis Date: 2012-03-12 Impact factor: 9.079
Authors: Rachel Brim; Sebastian Mboma; Margaret Semrud-Clikeman; Sam Kampondeni; Jed Magen; Terrie Taylor; John Langfitt Journal: Am J Trop Med Hyg Date: 2017-07 Impact factor: 2.345
Authors: Robert O Opoka; Paul Bangirana; Richard Idro; Estela Shabani; Ruth Namazzi; Chandy C John Journal: Pediatr Blood Cancer Date: 2017-08-17 Impact factor: 3.167
Authors: Dibyadyuti Datta; Andrea L Conroy; Peter F Castelluccio; John M Ssenkusu; Gregory S Park; Robert O Opoka; Paul Bangirana; Richard Idro; Andrew J Saykin; Chandy C John Journal: Clin Infect Dis Date: 2020-03-03 Impact factor: 9.079
Authors: Michael J Boivin; Noeline Nakasujja; Alla Sikorskii; Horacio Ruiseñor-Escudero; Itziar Familiar-Lopez; Kimberley Walhof; Esther M van der Lugt; Robert O Opoka; Bruno Giordani Journal: Brain Res Bull Date: 2018-03-06 Impact factor: 4.077
Authors: Itziar Familiar; Horacio Ruisenor-Escudero; Bruno Giordani; Paul Bangirana; Noeline Nakasujja; Robert Opoka; Michael Boivin Journal: J Dev Behav Pediatr Date: 2015-05 Impact factor: 2.225
Authors: John Mbaziira Ssenkusu; James Steven Hodges; Robert Opika Opoka; Richard Idro; Elsa Shapiro; Chandy Chiramukhathu John; Paul Bangirana Journal: Pediatrics Date: 2016-10-05 Impact factor: 7.124
Authors: Margaret Semrud-Clikeman; Regilda Anne A Romero; Elizabeth L Prado; Elsa G Shapiro; Paul Bangirana; Chandy C John Journal: Child Neuropsychol Date: 2016-09-09 Impact factor: 2.500